Immunization, Hib3 in Kyrgyzstan
Kyrgyzstan: Immunization, Hib3 was 84.0% in 2024. ▼ Falling
Immunization, Hib3 in Kyrgyzstan, 2010–2024
Source: WHO and UNICEF (http://www.who.int/immunization/monitoring_surveillance/en/). Measured in % of children ages 12-23 months.
Analysis
The most recent figure for immunization, hib3 in Kyrgyzstan is 84.0%, measured in 2024. That is the lowest value across all 15 years on record.
The figure is down 2.3% on the previous year and down 12.5% over ten years.
Over the whole period, immunization, hib3 in Kyrgyzstan peaked at 97.0% in 2013 and was at its lowest, 84.0%, in 2024.
Kyrgyzstan ranks 131st of 191 countries on this measure, in the middle of the range.
The long-run direction has been consistently falling across the 15 years of available data.
Immunization, Hib3 in Kyrgyzstan, year by year
| Year | % of children ages 12-23 months | Change |
|---|---|---|
| 2010 | 96.0% | — |
| 2011 | 96.0% | +0.0% |
| 2012 | 96.0% | +0.0% |
| 2013 | 97.0% | +1.0% |
| 2014 | 96.0% | -1.0% |
| 2015 | 97.0% | +1.0% |
| 2016 | 96.0% | -1.0% |
| 2017 | 92.0% | -4.2% |
| 2018 | 93.0% | +1.1% |
| 2019 | 94.0% | +1.1% |
| 2020 | 86.0% | -8.5% |
| 2021 | 88.0% | +2.3% |
| 2022 | 90.0% | +2.3% |
| 2023 | 86.0% | -4.4% |
| 2024 | 84.0% | -2.3% |
Kyrgyzstan compared with similar countries
- Kyrgyzstan's 84.0% is above the median for lower middle income countries, which is 84.0%, 1.0× the median. (47 countries reporting)
- Kyrgyzstan's 84.0% is below the median for Europe & Central Asia, which is 94.0%, 89% of the median. (50 countries reporting)
Averages by decade
| Decade | Average | Lowest | Highest | Years |
|---|---|---|---|---|
| 2010s | 95.3% | 92.0% | 97.0% | 10 |
| 2020s | 86.8% | 84.0% | 90.0% | 5 |
Countries ranked near Kyrgyzstan
More health data for Kyrgyzstan
- Un projection of annual infant deaths, annual growth rate -1.77 % change on previous year (2100)
- Heat deaths vs projected death rates, annual growth rate 0.6971 % change on previous year (2090)
- Estimated changes in temperature-related death rates compared to projected death rates 938.9 deaths per 1,000 people (2090)
- Number of infants who die before age 1 278 deaths (2100)
- Neonatal tetanus - number of reported cases, gaps filled 0 (2023)
- Population ages 00-04, female, annual growth rate -1.95 % change on previous year (2025)
- Population ages 00-04, female, per unit of GDP 0 units per US$ of GDP (2025)
- Population ages 00-04, female, per capita 0.0501 units per person (2025)
- Population ages 00-04, male, annual growth rate -2.01 % change on previous year (2025)
- Population ages 00-04, male, per unit of GDP 0 units per US$ of GDP (2025)
Frequently asked questions
- What is immunization, hib3 in Kyrgyzstan?
- Immunization, hib3 in Kyrgyzstan was 84.0% in 2024, according to WHO and UNICEF (http://www.who.int/immunization/monitoring_surveillance/en/).
- What is the highest immunization, hib3 recorded in Kyrgyzstan?
- The highest recorded value was 97.0% in 2013.
- What is the lowest immunization, hib3 recorded in Kyrgyzstan?
- The lowest recorded value was 84.0% in 2024.
- How does Kyrgyzstan rank for immunization, hib3?
- Kyrgyzstan ranks 131st out of 191 countries with data for 2024.
- Is immunization, hib3 rising or falling in Kyrgyzstan?
- Over the last ten years it is down 12.5%. The long-run trend across the full record is falling.
- Where does this Kyrgyzstan data come from?
- The figures come from WHO and UNICEF (http://www.who.int/immunization/monitoring_surveillance/en/), published as part of Immunization, Hib3 (% of children ages 12-23 months). Statizoid updates them automatically from the source API.
Download this data
CSV · JSON — 15 observations, free to reuse under CC BY 4.0 (World Bank Open Data).
About this data
Child immunization, Hib3, measures the percentage of children ages 12-23 months who received Hib3 vaccinations before 12 months or at any time before the survey. A child is considered adequately immunized against Hib3 after receiving three doses of Haemophilus influenzae type b vaccine.